Aldeyra The

Stock Chart, Company Information, and Scan Results

$1.24(as of Mar 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Aldeyra The Company Information, Fundamentals, and Technical Indicators

Stock Price$1.24
Ticker SymbolALDX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees8
CountyUSA
Market Cap$254.6M
EBIDTA-35.0M
10-Day Moving Average4.41
P/E Ratio-2.20
20-Day Moving Average4.83
Forward P/E Ratio0.00
50-Day Moving Average4.89
Earnings per Share-0.56
200-Day Moving Average4.87
Profit Margin-Infinity%
RSI17.61
Shares Outstanding60.2M
ATR0.62
52-Week High6.87
Volume52,152,074
52-Week Low1.14
Most Recent Support Level4.01
Book Value44,250,388.0M
Most Recent Resistance Level5.60
P/B Ratio0.00
Upper Keltner6.22
P/S RatioInfinity
Lower Keltner3.44
Debt-to-Equity Ratio6.22
Next Earnings Date04/30/2026
Cash Surplus42,232,324.0M
Next Ex-Dividend DateUnknown

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Aldeyra The In Our Stock Scanner

As of Mar 18, 2026
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Discounted Stocks with Earnings GrowthScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.